Skip to main content
Monthly Archives

March 2017

Mar 30
Love1

Research Park Tenant Founder selected as one of the all-time top 50 entrepreneurs

By News

Dr Sampson Hu has been selected as one of the all-time top 50 entrepreneurs by SetSquared

A Midlands entrepreneur been honoured with a place in a business hall of fame.

Dr Sampson Hu has been selected as one of the all-time top 50 entrepreneurs by SetSquared, a leading university technology growth body.

Dr Hu, 33, set up Smart Antenna Technologies (SAT) in 2013 after completing his studies at the University of Birmingham.

SAT has invented the world’s first multi antenna system for a laptops and smartphones.

Currently smartphones and laptops have up to five separate antenna for  Bluetooth, Wi Fi and 4G connections.

SAT technology combines all those antenna into one single system and can extend battery life by up to 10%.

SetSquared Partnership, the world’s leading university technology incubator, selected Dr Hu from over 1000 entrepreneurs that the organisation has helped grow over the past 15 years.

Dr Hu was honoured by MPs at the House of Commons (Wednesday 29 March) by the SetSquared Innovation Director Simon Bond.

Dr Hu, from Birmingham said: ‘I am honoured to be recognised by the world’s leading university incubator as one of their 50 all time entrepreneurs.

‘Building SAT up from nothing has been hard work for SAT’s team and myself but it was made easier with the help from SetSquared.’

Simon Bond, Innovation Director at SETsquared, said: “When I look back on the last 15 years, I am overwhelmed by the talent and achievements of the entrepreneurs that SETsquared has supported.

“They have brought world-leading innovations to market and these have been exported across the globe. SETsquared has provided support and a network for these entrepreneurs including access to mentors, experts, international markets and investors, and they are now out there doing SETsquared and the UK proud.”

Dr Sampson Hu has been selected as one of the all-time top 50 entrepreneurs by SetSquared

 

Mar 16
Love1

Birmingham company showcases UK healthcare excellence in Texas

By News

A Birmingham healthcare company waved the British flag of innovation last week when they took part in a pioneering Medical Technology (MedTech) mission across Texas.

Based at the BioHub at Birmingham Research Park, Rightangled Diagnostics was one of six UK companies chosen to take part in the mission to showcase UK healthcare excellence.

 

The biotech company, who specialise in cardiac health, use the latest advancements in biotechnology and genetic testing in order to help patients at an increased risk of developing certain heart conditions, and to help optimise their drug prescription.

 

Throughout the week-long visit to the State, Rightangled Diagnostics visited leading health organisations across Texas in a bid to explore future partnering opportunities.

The unique visit offered the company an opportunity to connect with a variety of healthcare systems, R&D, buying and professional organisations at the highest levels. The objective was to foster new relationships and adopt cutting-edge medical technologies into the state.

For Texan-based organisations, it is an important opportunity to learn about and engage with the UK’s health system and understand how the market works.

The visit was organised by the Association of British Healthcare Industries (ABHI) and is supported by the UK government.

Founder and CEO of Rightangled Diagnostics Abdullah Sabyah, said: “The trip was a great experience and an invaluable opportunity to meet and network with key decision-making individuals at the highest levels inside hospitals and prominent healthcare establishments in the State. It was great to showcase Birmingham and the UK in Texas.”

Texas is the seventh largest health economy in the world and has significant ambition to be a global healthcare and life sciences player over the next decade. The tour began in Houston, before moving to Dallas and Austin.

The visit was timed to coincide with the health track of South by Southwest (SXSW) thus providing a further opportunity to meet with leaders in health and technology.

 

ENDS 

More information about the ABHI

The Association of British Healthcare Industries (ABHI) is the industry association for the medical technology sector in the UK.

ABHI’s mission is to champion the benefits and use of safe and effective medical technologies to deliver high quality patient outcomes. With over 250 members, the ABHI leads the advocacy of the industry in order to advance access to medical technology.

Their membership includes some of the leading multinational businesses in the sector in the UK; right the way through to small and medium sized enterprises (SMEs). Each year, the ABHI organises the UK Pavilions at leading medical technology exhibitions including MEDICA and Arab Health.

For further information visit: www.abhi.org.uk

Mar 07
Love1

Drop-In Information session on Funding Opportunities for SMEs 30th March 2017

By News

FUNDING OPPORTUNITIES FOR SMES – INFORMATION SESSION AT BIRMINGHAM RESEARCH PARK : 30TH MARCH 2017 2—4PM

Birmingham City Council’s new £33 million Business Growth Programme (BGP) is a comprehensive business support package designed to strengthen supply chains, stimulate innovation and grow existing SMEs across Greater Birmingham and Solihull

The Business Innovation Programme is aimed at existing B2B Small to Medium sized Enterprises (SMEs) investing in innovative ”close-to-market”  products and services. Capital and revenue grants are available of £10,000 to £30,000

The Business Development Programme is aimed at existing B2B Small to Medium sized Enterprises (SMEs) looking to expand, relocate and improve access to markets. Capital and revenue grants are available of £10,000 to £20,000.

The HS2 Supply Chain Programme is targeted at existing B2B supply chain Small to Medium sized Enterprises (SMEs) which have, or are in the process of securing, or have the ability to secure a contract for HS2.

The Green Bridge Supply Chain Programme is targeted at existing B2B Small to Medium sized Enterprises (SME) supply chain companies operating in, or expanding into the green economy, demonstrating quantifiable green benefit (i.e. energy efficiency, waste management, recycling and renewables).

Part-funded by the European Regional Development Fund (ERDF) and in partnership with Stoke-on-Trent and Staffordshire and The Marches Local Enterprise Partnerships (LEPs).

Meet the Business Development and Innovation Team and find out more at a drop in session at Birmingham Research Park: 2- 4pm. Conference Room B on the ground floor.

Mar 01
Love1

Proton Partners International Announces The Rutherford Cancer Centres

By News

Proton Partners International has announced on the 22nd of February 2017 that it is to name its clinics The Rutherford Cancer Centres.

The Rutherford Cancer Centres will offer patients a comprehensive range of cancer treatments and, from 2018, will be the first in the UK to offer high energy proton beam therapy.

The oncology centres have been named to reflect the renowned scientist Ernest Rutherford’s contribution in identifying and naming the proton in 1911.

Three centres are currently under development, in Newport, South Wales, Bomarsund, Northumberland and Reading, Berkshire. The Rutherford Cancer Centre, South Wales is nearing completion and will offer chemotherapy, radiotherapy and imaging via the latest planning and treatment technologies. Positron emission tomography–computed tomography (PET-CT) will be available in the second half of this year and proton beam therapy will be available at the centre from early 2018.

Treatment at The Rutherford Cancer Centres will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.

Professor Gordon McVie, chairman of Proton Partners International, said: “We’re delighted to announce the creation of The Rutherford Cancer Centres.

“Proton Partners International is committed to transforming cancer care in the UK. The Rutherford name is synonymous with a major breakthrough in cancer treatment and therefore we felt that this was a fitting identity for our treatment centres.

“With cancer on the rise, there is a growing need for patients to be offered a holistic and sophisticated level of cancer care.  Patients at The Rutherford Cancer Centres will have access to a wide range of cancer services and a treatment plan will be implemented on an individual basis.”

Mike Moran, chief executive officer of Proton Partners International, said: “We are working with the world’s leading technology partners to ensure that our centres are equipped with the latest cancer technology.

“Our centres will have the capacity to treat 500 unique patients a year. We will also network our centres to ensure the data they will provide can play a significant role in cancer research. We are committed to undertaking a genomics programme which will collate, analyse and distribute data through our research facility at the Life Sciences Accelerator centre in Liverpool.”

http://www.proton-int.com/